Rapid reversal of quadraparesis in chronic eosinophilic leukaemia expressing the FIP1L1-PDGFRA transcript after therapy with imatinib

Leuk Res. 2011 Mar;35(3):e15-7. doi: 10.1016/j.leukres.2010.10.026. Epub 2010 Nov 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Chronic Disease
  • Humans
  • Hypereosinophilic Syndrome / complications
  • Hypereosinophilic Syndrome / drug therapy
  • Hypereosinophilic Syndrome / genetics*
  • Imatinib Mesylate
  • Magnetic Resonance Imaging
  • Male
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Quadriplegia / drug therapy*
  • Quadriplegia / etiology*
  • RNA, Messenger / genetics
  • Receptor, Platelet-Derived Growth Factor alpha / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • mRNA Cleavage and Polyadenylation Factors / genetics*

Substances

  • Antineoplastic Agents
  • Benzamides
  • FIP1L1 protein, human
  • Piperazines
  • Pyrimidines
  • RNA, Messenger
  • mRNA Cleavage and Polyadenylation Factors
  • Imatinib Mesylate
  • Receptor, Platelet-Derived Growth Factor alpha